GST makes ‘orphan drugs’ prices soar
These high-value ‘orphan’ drugs used in bone marrow transplant, classical Hodgkin Lymphoma, Crohn’s disease and melanoma.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news
More News: Biotechnology | Bone Marrow Transplant | Hodgkin's Disease | Lymphoma | Melanoma | Pharmaceuticals | Skin Cancer | Transplants